Risk of Postdischarge Infection with Vancomycin-Resistant Enterococcus after Initial Infection or Colonization

被引：8

作者：

Datta, Rupak ^{[1
,2
]}

Huang, Susan S. ^{[1
,2
,3
]}

机构：

[1] Univ Calif Irvine, Sch Med, Hlth Policy Res Inst, Irvine, CA 92697 USA

[2] Univ Calif Irvine, Sch Med, Div Infect Dis, Irvine, CA 92697 USA

[3] Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA

来源：

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY | 2010年 / 31卷 / 12期

基金：

美国国家卫生研究院;

关键词：

BLOOD-STREAM INFECTION; FAECIUM; CANCER;

D O I：

10.1086/657332

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

Postdischarge risks of vancomycin-resistant Enterococcus (VRE) infection among carriers are unknown. We conducted a retrospective cohort study of 199 patients newly detected as VRE carriers. Fifteen patients (8%) developed 27 VRE infections in the 18 months after detection. Among 10 postdischarge infections, 2 involved bacteremia and 3 resulted in readmission.

引用

页码：1290 / 1293

页数：4

共 10 条

[1] Duration of colonization with vancomycin-resistant Enterococcus [J].

Byers, KE ;

Anglim, AM ;

Anneski, CJ ;

Farr, BM .

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2002, 23 (04) :207-211

[2]

Clinical and Laboratory Standards Institute (CLSI), 2007, M100S17 CLSI

[3]

DEFRANCES CJ, 2008, 5 CDCP

[4] VANCOMYCIN-RESISTANT ENTEROCOCCUS-FAECIUM BACTEREMIA - RISK-FACTORS FOR INFECTION [J].

EDMOND, MB ;

OBER, JF ;

WEINBAUM, DL ;

PFALLER, MA ;

HWANG, T ;

SANFORD, MD ;

WENZEL, RP .

CLINICAL INFECTIOUS DISEASES, 1995, 20 (05) :1126-1133

[5] Insights into the epidemiology and control of infection with vancomycin-resistant enterococci [J].

Hayden, MK .

CLINICAL INFECTIOUS DISEASES, 2000, 31 (04) :1058-1065

[6]

Horan T.C., 2004, HOSP EPIDEMIOLOGY IN, V3rd, P1659

[7] Association between mucositis severity and vancomycin-resistant enterococcal bloodstream infection in hospitalized cancer patients [J].

Kuehnert, MJ ;

Jernigan, JA ;

Pullen, AL ;

Rimland, D ;

Jarvis, WR .

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 1999, 20 (10) :660-663

[8]

Montecalvo MA, 1995, INFECT CONT HOSP EP, V16, P680

[9] Clinical impact of vancomycin-resistant enterococci [J].

Patel, R .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 51 :13-21

[10] Risk factors for development of vancomycin-resistant enterococcal bloodstream infection in patients with cancer who are colonized with vancomycin-resistant enterococci [J].

Zaas, AK ;

Song, XY ;

Tucker, P ;

Perl, TM .

CLINICAL INFECTIOUS DISEASES, 2002, 35 (10) :1139-1146

← 1 →